Cholera Vaccines Market Size, Share, Growth, Trends with Impact of Covid-19 and Forecast by 2022-2030
SKU ID : INH-18092970 | Publishing Date : 26-Apr-2021 | No. of pages : 100
Cholera Vaccines Market Report is projected to grow at a CAGR of XX% during the forecast period 2021-2024.
Company Coverage: -
- Astellas Pharma Inc.
- AstraZeneca
- Emergent BioSolutions Inc.
- GlaxoSmithKline plc (GSK)
- Merck & Co. Inc.
- Mitsubishi Tanabe Pharma Corporation
- PaxVax Inc.
- Pfizer Inc.
- Shantha Biotechnics Private Limited
- Takeda Pharmaceutical Co. Ltd
- Valneva SE
Scope: -
Cholera is caused by Vibrio cholerae via the consumption of contaminated food or water. The infected individuals suffer from severe watery diarrhea, eventually leading to dehydration, which if unattended, may lead to death, owing to access water loss. Oral vaccination has been observed to be the best preventive treatment for cholera and has proved to be very useful to prevent huge outbreaks. There are two basic types of vaccines given for cholera: whole-cell V. cholerae O1, in combination with a recombinant B-subunit of cholera toxin (WC/rBS), and killed oral O1 and O139.
Regions: -
- North America
- Asia-Pacific
- Europe
- South America
- Africa
Key Highlights of Report:
- Provides market definition and overview by studying objectives like market scope and market size estimation.
- Provides research methods and logic based on historic data.
- Analysis market competition, market performance worldwide, manufactures basic information, Sales, Value, Price and Gross Margin.
- Analysis on segmentation of types, applications and regions based on historical Data and market forecasts.
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region